CMV Retinitis Retreatment Trial
Public ClinicalTrials.gov record NCT00000766. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To assess the safety and efficacy of three therapeutic regimens (foscarnet, ganciclovir, or the combination) for recurrent or persistent AIDS-related cytomegalovirus (CMV) retinitis. Although therapy with foscarnet or ganciclovir halts retinitis progression in 90 percent of patients treated, relapses are common and may accelerate due to development of drug resistance, deteriorating immune function, or other factors. Treatment strategies currently being investigated include switching patients from one drug to the other or combining the two drugs.
Study identification
- NCT ID
- NCT00000766
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Sep 1995 (Actual)
- Completion
- Not listed
- Last update posted
- Mar 1, 2011
United States locations
- U.S. sites
- 9
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSD - Shiley Eye Ctr / SOCA | La Jolla | California | 920930946 | — |
| UCLA - Jules Stein Eye Institute / SOCA | Los Angeles | California | 900957003 | — |
| UCSF - San Francisco Gen Hosp | San Francisco | California | 94143 | — |
| Northwestern Univ / SOCA | Chicago | Illinois | 60611 | — |
| Johns Hopkins Hosp / SOCA | Baltimore | Maryland | 212879217 | — |
| New York Univ Med Ctr / SOCA | New York | New York | 10016 | — |
| New York Hosp - Cornell Med Ctr / Sloan - Kettering / SOCA | New York | New York | 10021 | — |
| Mount Sinai Med Ctr / SOCA | New York | New York | 100296574 | — |
| Univ of North Carolina / SOCA | Chapel Hill | North Carolina | 275997030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00000766, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 1, 2011 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00000766 live on ClinicalTrials.gov.